Author: Piers Townley

COVID-19 has dramatically transformed the research landscape for our community but we remain driven to accelerate new treatments.

Researcher Till Milde and his team from the Hopp Children’s Cancer Center Heidelberg (KiTZ) have developed a new test system.

The NIHR announced yesterday that they have published a framework for restarting research activities that have a been paused as a result of Covid-19.

Sally Bramall says fundraising for research even more vital during this COVID-19 crisis.

This collaborative plan will award outstanding neuro-oncology centres ‘Tessa Jowell Centre’ status within weeks.

Dominic is a former defender who played for, among others, Liverpool, Leeds and Scotland during a 15-year career is recovering from a brain tumour diagnosis.

The Center for Advancing Innovation (CAI) announces winners of the Brain Race, an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors.

Olympian Tom Daley will take on the 2.6 challenge with 26 Olympians from Team GB on Sunday.

The charity industry’s leading organisation lists The Brain Tumour Charity as one of the best to work for .

Join us in the nationwide 2.6 challenge and help our community raise vital funds for research

As part of its response to the coronavirus COVID-19 pandemic, the Government identified individuals who are ‘extremely vulnerable’ – that is, those at ‘very high risk of severe illness’ from the virus.

Scientists carried out a large-scale study of 241 infants from around the world.

Since the vote for Brexit in 2016, there has been the possibility of the UK leaving the EU without a deal. Consequently, to avoid disruption if supply routes from the EU were affected, the Government asked pharmaceutical companies to stockpile an extra six weeks’ worth of medicines.

When her grandson Logan died from a DIPG brain tumour in 2017, Fiona vowed to drive change for everyone affected.

With the UK in the Brexit transition period until the end of the year, regulation of clinical trials is likely to be under discussion in UK-EU negotiations on the future relationship

Last week, our first lab tour of 2020 gave some of our supporters a chance to witness our funded research first-hand.

Today we have heard the incredibly sad news of Martino Sclavi’s passing. He has been a driving force in much of our work and a huge advocate for the entire brain tumour community.

Early this morning, the teams strapped on their skiis and headed to the slopes to take on Everest In The Alps 2020.

An affordable, point of care blood test to diagnose brain tumours was announced today by The University of Bristol.

The level of funding into the research of brain tumours in the UK has increased overall by a third, according to figures released by the National Cancer Research Institute (NCRI).

On January 31, the UK formally left the European Union (EU). As a result, we have now entered into an 11-month transition period, as the future UK-EU relationship is negotiated.

In April, NHSX, the unit whose remit is to deliver the digital transformation of the health service, will begin running a new artificial intelligence (AI) Lab.

In just over three weeks time, the teams including presenter Phil Spencer, are set to tackle the Alpine slopes.

The TV presenter and radio broadcaster, one of our High Profile Supporters, is committed to helping us raise awareness.